Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

2.

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N.

Cancer. 1999 Aug 1;86(3):429-38.

PMID:
10430251
3.

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.

Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, Wolmark N.

Cancer. 1996 Oct 1;78(7):1403-16.

6.

Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results.

Sneige N, McNeese MD, Atkinson EN, Ames FC, Kemp B, Sahin A, Ayala AG.

Hum Pathol. 1995 Jun;26(6):642-9. Review.

PMID:
7774895
7.
8.

Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS).

Fowble B, Hanlon AL, Fein DA, Hoffman JP, Sigurdson ER, Patchefsky A, Kessler H.

Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):949-57.

PMID:
9276359
9.

Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.

Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM.

Cancer. 2004 Feb 1;100(3):490-8.

10.

Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.

Boyages J, Delaney G, Taylor R.

Cancer. 1999 Feb 1;85(3):616-28.

PMID:
10091735
11.

Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome.

Cox CE, Hyacinthe M, Gonzalez RJ, Lyman G, Reintgen D, Ku NN, Miller MS, Greenberg H, Nicosia SV.

Ann Surg Oncol. 1997 Dec;4(8):644-9.

PMID:
9416412
13.

The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.

Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):105-15.

PMID:
9747827
14.

Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.

Fisher ER, Land SR, Saad RS, Fisher B, Wickerham DL, Wang M, Costantino JP, Wolmark N.

Am J Clin Pathol. 2007 Jul;128(1):86-91.

PMID:
17580274
15.

Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06.

Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N.

Cancer. 2001 Apr 15;91(8 Suppl):1679-87.

PMID:
11309768
16.

Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.

Van Zee KJ, Liberman L, Samli B, Tran KN, McCormick B, Petrek JA, Rosen PP, Borgen PI.

Cancer. 1999 Nov 1;86(9):1757-67.

PMID:
10547549
17.

Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.

Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D.

Am J Clin Oncol. 2009 Jun;32(3):314-8. doi: 10.1097/COC.0b013e31818af0b9.

PMID:
19451803
18.
19.

Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.

Dzierzanowski M, Melville KA, Barnes PJ, MacIntosh RF, Caines JS, Porter GA.

J Surg Oncol. 2005 May 1;90(2):71-6.

PMID:
15844190

Supplemental Content

Support Center